Back to Screener

Healthcare

Syros Pharmaceuticals, Inc.(SYRS)

Live Price

Offline

$0.0001

-75.00% today

1Y Change

-99.63%

Window

Jun 23, 2025 โ†’ Jun 18, 2026

Market Cap
โ€”
Revenue Growth
-33.2%
EPS Growth
+22.4%
Dividend Yield
0.0%

Coverage: 240 bars ยท Jun 23, 2025 โ†’ Jun 18, 2026

Research Briefing

A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.

Decision context

Research Snapshot

Syros Pharmaceuticals, Inc. (SYRS) is a Healthcare stock with listed on OTC. The stock last traded around $0.00 and down 99.6% across the available one-year price window (Jun 23, 2025 โ†’ Jun 18, 2026). Baseline metrics include revenue growth of -33.2%, EPS growth of +22.4%, a dividend yield of 0.0%. What stands out right now is revenue -33.2%, EPS +22.4%, free cash flow +11.5% with operating margin -1298.2% and ROIC -91.8%. Valuation is more restrained than many high-expectation growth names at price/sales 0.0. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines SYRS price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.

Benchmark Comparison

Normalized Performance vs SPY

Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.

1Y shared range

SYRS

โ€”

Normalized return

SPY

โ€”

S&P 500

Excess Return

โ€”

Relative to SPY

SYRS Max Drawdown

-99.67%

Trailing 1Y

SPY Max Drawdown

โ€”

Trailing 1Y

Benchmark comparison is loading or unavailable right now.

Calendar-Year Returns

Uses the longest available daily history for SYRS and SPY.

Calendar-year return history is still loading or unavailable.

Earnings Reports

๐Ÿ“… Last reportedMay 12, 2026
PeriodB/MEPSEPS ฮ”RevenueRev ฮ”Report
โ€”
May 12, 26
โ€”
Est โ€”
โ€”
โ€”
Est โ€”
โ€”
May 12
โ€”
Mar 25, 26
โ€”
Est -0.16
โ€”
โ€”
Est โ€”
โ€”
Mar 25
โ€”
Oct 29, 25
โ€”
Est โ€”
โ€”
โ€”
Est โ€”
โ€”
Oct 29
โ€”
Aug 4, 25
โ€”
Est โ€”
โ€”
โ€”
Est โ€”
โ€”
Aug 4
โ€”
May 20, 25
โ€”
Est -0.70
โ€”
โ€”
Est โ€”
โ€”
May 20
โ€”
Mar 26, 25
โœ—
-1.19
Est -0.70
-70.0%
โ€”
Est โ€”
โ€”
Mar 26
โ€”
Oct 31, 24
โœ“
-0.68
Est -0.76
+10.5%
โ€”
Est 450.0B
โ€”
Oct 31
โ€”
Jul 31, 24
โœ“
-0.70
Est -0.79
+11.4%
โ€”
Est 460.0B
โ€”
Jul 31
โ€”
May 14, 24
โœ“
-0.79
Est -0.89
+11.2%
โ€”
Est 720.0B
โ€”
May 14
โ€”
Mar 27, 24
โœ“
-1.19
Est -1.23
+3.3%
386.0B
Est 2000.0B
-80.7%
Mar 27
โ€”
Nov 14, 23
โœ—
-1.35
Est -1.12
-20.5%
3762.0B
Est 2000.0B
+88.1%
Nov 14
โ€”
Aug 8, 23
โœ—
-1.30
Est -1.11
-17.1%
2833.0B
Est 3500.0B
-19.1%
Aug 8
โ€”
May 10, 23
โœ“
-0.85
Est -1.12
+24.1%
2954.0B
Est 3260.0B
-9.4%
May 10
โ€”
Mar 2, 23
โœ—
-1.28
Est -1.27
-0.8%
-5467.0B
Est 3850.0B
-242.0%
Mar 2
โ€”
Nov 14, 22
โœ“
-2.41
Est -3.91
+38.4%
3891.0B
Est 5180.0B
-24.9%
Nov 14
โ€”
Aug 9, 22
โœ—
-5.40
Est -4.20
-28.6%
6276.0B
Est 4740.0B
+32.4%
Aug 9
โ€”
May 16, 22
โœ“
-4.00
Est -4.80
+16.7%
5467.0B
Est 4923.6B
+11.0%
May 16
โ€”
Mar 15, 22
โœ“
-4.20
Est -4.40
+4.5%
7802.0B
Est 4807.1B
+62.3%
Mar 15
โ€”
Nov 5, 21
โœ“
-4.10
Est -4.30
+4.7%
5697.0B
Est 4390.0B
+29.8%
Nov 5
โ€”
Aug 5, 21
โ€”
-3.60
Est -3.60
0.0%
5162.0B
Est 4130.0B
+25.0%
Aug 5
No upcoming earnings in the next 90 days

Next Step

Connect reports to catalysts

Earnings pages get much more useful when they are tied back to upcoming dates, expectations, and peer setups.

Read the earnings calendar guideOpen the calendar screener